These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33963786)

  • 1. Immune Checkpoint-Bioengineered Beta Cell Vaccine Reverses Early-Onset Type 1 Diabetes.
    Au KM; Medik Y; Ke Q; Tisch R; Wang AZ
    Adv Mater; 2021 Jun; 33(25):e2101253. PubMed ID: 33963786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-Onset Type 1 Diabetes.
    Yang Z; Zhang Z; Li L; Jing Z; Ma Y; Lan T; Li Y; Lin Z; Fang W; Zhang J; Zhang J; Liang X; Wu B; Zheng Y; Zhang X
    Diabetes; 2024 Aug; 73(8):1325-1335. PubMed ID: 38771941
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Au KM; Tisch R; Wang AZ
    ACS Nano; 2021 Dec; 15(12):19990-20002. PubMed ID: 34843648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered PD-L1-Expressing Platelets Reverse New-Onset Type 1 Diabetes.
    Zhang X; Kang Y; Wang J; Yan J; Chen Q; Cheng H; Huang P; Gu Z
    Adv Mater; 2020 Jul; 32(26):e1907692. PubMed ID: 32449212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells.
    Rajasalu T; Brosi H; Schuster C; Spyrantis A; Boehm BO; Chen L; Reimann J; Schirmbeck R
    Diabetes; 2010 Aug; 59(8):1966-73. PubMed ID: 20484136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide gene expression profiling reveals that CD274 is up-regulated new-onset type 1 diabetes mellitus.
    Fang C; Huang Y; Pei Y; Zhang HH; Chen X; Guo H; Li S; Ji X; Hu J
    Acta Diabetol; 2017 Aug; 54(8):757-767. PubMed ID: 28577136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Checkpoint Ligand Bioengineered Schwann Cells as Antigen-Specific Therapy for Experimental Autoimmune Encephalomyelitis.
    Au KM; Tisch R; Wang AZ
    Adv Mater; 2022 Feb; 34(5):e2107392. PubMed ID: 34775659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptophan metabolism promotes immune evasion in human pancreatic β cells.
    Rachdi L; Zhou Z; Berthault C; Lourenço C; Fouque A; Domet T; Armanet M; You S; Peakman M; Mallone R; Scharfmann R
    EBioMedicine; 2023 Sep; 95():104740. PubMed ID: 37536063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.
    Kawada-Horitani E; Kita S; Okita T; Nakamura Y; Nishida H; Honma Y; Fukuda S; Tsugawa-Shimizu Y; Kozawa J; Sakaue T; Kawachi Y; Fujishima Y; Nishizawa H; Azuma M; Maeda N; Shimomura I
    Diabetologia; 2022 Jul; 65(7):1185-1197. PubMed ID: 35511238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protecting Stem Cell Derived Pancreatic Beta-Like Cells From Diabetogenic T Cell Recognition.
    Castro-Gutierrez R; Alkanani A; Mathews CE; Michels A; Russ HA
    Front Endocrinol (Lausanne); 2021; 12():707881. PubMed ID: 34305820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in situ dual-anchoring strategy for enhanced immobilization of PD-L1 to treat autoimmune diseases.
    Wang S; Zhang Y; Wang Y; Yang Y; Zhao S; Sheng T; Zhang Y; Gu Z; Wang J; Yu J
    Nat Commun; 2023 Oct; 14(1):6953. PubMed ID: 37907476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
    Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
    Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes.
    Osum KC; Burrack AL; Martinov T; Sahli NL; Mitchell JS; Tucker CG; Pauken KE; Papas K; Appakalai B; Spanier JA; Fife BT
    Sci Rep; 2018 May; 8(1):8295. PubMed ID: 29844327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the PD-1/PD-L1 Dyad in the Maintenance of Pancreatic Immune Tolerance for Prevention of Type 1 Diabetes.
    Falcone M; Fousteri G
    Front Endocrinol (Lausanne); 2020; 11():569. PubMed ID: 32973682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes.
    Ben Nasr M; Tezza S; D'Addio F; Mameli C; Usuelli V; Maestroni A; Corradi D; Belletti S; Albarello L; Becchi G; Fadini GP; Schuetz C; Markmann J; Wasserfall C; Zon L; Zuccotti GV; Fiorina P
    Sci Transl Med; 2017 Nov; 9(416):. PubMed ID: 29141886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioengineering strategies for inducing tolerance in autoimmune diabetes.
    Baekkeskov S; Hubbell JA; Phelps EA
    Adv Drug Deliv Rev; 2017 May; 114():256-265. PubMed ID: 28625830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A missing PD-L1/PD-1 coinhibition regulates diabetes induction by preproinsulin-specific CD8 T-cells in an epitope-specific manner.
    Schuster C; Brosi H; Stifter K; Boehm BO; Schirmbeck R
    PLoS One; 2013; 8(8):e71746. PubMed ID: 23977133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leverage biomaterials to modulate immunity for type 1 diabetes.
    Jing Z; Li Y; Ma Y; Zhang X; Liang X; Zhang X
    Front Immunol; 2022; 13():997287. PubMed ID: 36405706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.
    Ezquer F; Ezquer M; Contador D; Ricca M; Simon V; Conget P
    Stem Cells; 2012 Aug; 30(8):1664-74. PubMed ID: 22644660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes.
    Quandt Z; Young A; Anderson M
    Clin Exp Immunol; 2020 May; 200(2):131-140. PubMed ID: 32027018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.